비은계 항균 드레싱 시장 - 세계 및 지역별 분석 : 지역별, 국가별 분석, 경쟁 구도 - 분석 및 예측(2023-2030년)
Non-Silver Antimicrobial Dressings Market - A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2030
상품코드:1489283
리서치사:BIS Research
발행일:2024년 06월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계 비은계 항균 드레싱 시장 규모는 2022년 4억 2,090만 달러에 달할 것으로 예상되며 견조한 성장세를 보이고 있습니다.
이 시장은 2030년 5억 6,580만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 3.75%의 성장률을 나타낼 것으로 전망됩니다. 비은계 항균 드레싱 재료는 만성 상처 관리 및 감염 예방에 효과적인 솔루션을 제공함으로써 고급 상처 치료에서 매우 중요한 도구로 부상하고 있습니다.
주요 시장 통계
예측 기간
2023-2030년
2023년 평가
4억 3,720만 달러
2030년 전망
5억 6,580만 달러
CAGR
3.75%
만성질환의 발병률이 높아지고 감염 예방에 대한 인식이 높아지면서 드레싱에 대한 수요는 전 세계적으로 급증하고 있습니다.
이 보고서는 세계의 비은계 항균 드레싱 시장에 대해 조사했으며, 시장 개요와 함께 지역별, 국가별 동향, 시장 진출기업의 경쟁 구도 등을 정리하여 전해드립니다.
목차
주요 요약
제1장 시장
제품 정의
포함 기준과 제외 기준
주요 질문에 대한 답변
분석과 예측 노트
주요 조사 결과
제2장 지역
지역별 개요
북미
미국
캐나다
유럽
독일
오스트리아
체코
그리스
폴란드
루마니아
러시아 연방
슬로바키아
터키
우크라이나
벨기에
덴마크
핀란드
프랑스
아일랜드
이탈리아
네덜란드
노르웨이
포르투갈
스페인
스웨덴
스위스
영국
아시아태평양
호주
중국
인도
일본
말레이시아
한국
태국
라틴아메리카
아르헨티나
브라질
칠레
콜롬비아
멕시코
세계 기타 지역
제3장 시장 - 경쟁 벤치마킹
주요 전략과 개발
주요 기업 에코시스템
제4장 조사 방법
LSH
영문 목차
영문목차
Introduction of Non-Silver Antimicrobial Dressings
The global non-silver antimicrobial dressings market, valued at $420.9 million in 2022, is on a robust growth trajectory and is anticipated to reach $565.8 million by 2030. This market is expected to expand at a compound annual growth rate (CAGR) of 3.75% between 2023 and 2030. Non-silver antimicrobial dressings have emerged as pivotal tools in advanced woundcare, offering effective solutions in managing chronic wounds and preventing infections.
Market Introduction
KEY MARKET STATISTICS
Forecast Period
2023 - 2030
2023 Evaluation
$437.2 Million
2030 Forecast
$565.8 Million
CAGR
3.75%
With the rising incidence of chronic diseases, coupled with growing awareness of infection control measures, the demand for these dressings continues to surge globally. This introduction provides a glimpse into the dynamic landscape of the non-silver antimicrobial dressings market, poised for significant expansion in the coming years.
Regional Segmentation:
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Netherlands
Switzerland
Russian Federation
Turkey
Poland
Belgium
Sweden
Ireland
Norway
Austria
Denmark
Finland
Portugal
Czech Republic
Romania
Greece
Slovakia
Ukraine
Asia-Pacific
Japan
China
India
South Korea
Australia
Malaysia
Thailand
Latin America
Brazil
Mexico
Colombia
Argentina
Chile
Rest-of-the-World
The regional analysis of the non-silver antimicrobial dressing market reveals a diversified landscape, with North America leading in market share, followed by Europe, Asia-Pacific, Latin America, and the Rest-of-the-World. North America, with a market value of $206.8 million in 2022, is anticipated to maintain its dominance throughout the forecast period, driven by factors such as advanced healthcare infrastructure, high adoption of advanced wound care products, and increasing prevalence of chronic wounds. Europe, with a market value of $104.6 million in 2022, is expected to witness steady growth propelled by rising healthcare expenditure and a growing aging population. Asia-Pacific is expected to emerge as the fastest-growing region with a CAGR of 4.57% from 2022 to 2030, fueled by expanding healthcare facilities, rising awareness of wound care management, and the presence of key market players investing in the region. Latin America and the Rest-of-the-World regions are also expected to show promising growth opportunities, driven by improving healthcare infrastructure and a rising focus on wound care management. This regional analysis underscores the global scope and potential of the non-silver antimicrobial dressing market, with each region contributing uniquely to its overall growth trajectory.
Recent Developments in the Non-Silver Antimicrobial Dressings Market
In November 2023, Kane Biotech Inc., together with ProgenaCare Global LLP ("ProgenaCare"), announced the introduction of the newly rebranded Revyve Antimicrobial Wound Gel, previously known as Coactiv+ Antimicrobial Wound Gel.
In May 2023, Kane Biotech Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its coactiv+ Antimicrobial Wound Gel. This clearance permits the use of the gel for managing various wounds in adults, including ulcers (such as diabetic foot and leg and pressure ulcers), first and second-degree burns, partial and full-thickness wounds, large surface area wounds, and surgical incisions.
In February 2022, Argentum Medical, a leader in medical devices backed by Shore Capital and a pioneer in silver-plated nylon technology, announced its acquisition of Anacapa Technologies' product lines, including antimicrobial wound cleansers, gels, and irrigation solutions. Anacapa Technologies has been recognized as a market leader and innovator in developing antimicrobial wound care products.
In June 2021, at RMIT University, Australia, researchers created advanced wound dressings equipped with embedded nanosensors that emit a glow to notify patients of improper healing. These multifunctional, antimicrobial dressings have been designed with fluorescent sensors that light up under UV light when an infection is present, allowing for monitoring of the healing process.
How can this Report add value to an Organization?
Product/Innovation Strategy: The market analysis provides insights into specific customer needs, enabling organizations to develop customized non-silver antimicrobial dressings that address unique regional requirements, such as climate conditions or prevalent wound types.
Growth/Marketing Strategy: The market analysis allows organizations to implement targeted marketing campaigns tailored to the preferences and behaviors of consumers in that specific region, leading to more effective customer engagement and higher conversion rates.
Competitive Strategy: Organizations can differentiate their non-silver antimicrobial dressings by highlighting features or benefits that are particularly valued by customers in the regional market, such as affordability, ease of use, or compatibility with local wound care protocols.
Methodology
Key Considerations and Assumptions in Market Engineering and Validation
The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2030.
The scope of this report has been carefully derived based on interactions with experts in different companies worldwide. This report provides a market study of upstream and downstream products of non-silver antimicrobial dressings.
The market contribution of non-silver antimicrobial dressings anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
The market has been mapped based on the available non-silver antimicrobial dressings. This report has considered and profiled all the key companies with significant offerings in this field.
Primary Research:
The primary sources involve industry experts in non-silver antimicrobial dressings, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:
Validation and triangulation of all the numbers and graphs
Validation of the report's segmentation and key qualitative findings
Understanding the competitive landscape and business model
Current and proposed production values of a product by market players
Percentage split of individual markets for regional analysis
Secondary Research:
Open Sources
Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
Annual reports, SEC filings, and investor presentations of the leading market players
Company websites and detailed study of their product portfolio
Gold standard magazines, journals, white papers, press releases, and news articles
Paid databases
The key data points taken from the secondary sources include:
Segmentations and percentage shares
Data for market value
Key industry trends of the top players of the market
Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
Quantitative data for mathematical and statistical calculations
Key Market Players and Competition Synopsis
The non-silver antimicrobial dressings market has been witnessing intensified competition as key players strive to capitalize on growing demand fueled by the rising incidence of chronic wounds and infections globally. Market leaders are leveraging advanced technologies and strategic collaborations to enhance product efficacy and expand their geographical reach. Innovations in biomaterials and antimicrobial agents are driving product differentiation, while stringent regulatory requirements pose a barrier to entry for new entrants. Moreover, the market has been characterized by a shift toward sustainable and biocompatible materials, driving companies to invest in research and development to gain a competitive edge.
Some prominent names established in this market are:
